NL-OMON38405已完成2 期
Optimizing Pain Treatment in Pre-Term Neonates - Morphine study
适应症
试验速览
- 阶段
- 2 期
- 状态
- 已完成
- 入组人数
- 30
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 2 至 11（—）
入选标准
- •Preterm neonates of both genders and all races between 23 and 32 weeks
- •postnatal age less than 30 days
- •an indwelling (peripheral or umbilical) arterial line, and
- •a clinical indication for intravenous morphine administration
排除标准
- •Neonates with severe asphyxia, grade III or IV intraventricular hemorrhage, major congenital malformations/facial malformations, neurological disorders, and those receiving continuous or intermittent neuromuscular blockers.
- •clinical or biochemical evidence of hepatic and renal compromise (including systemic hypoperfusion) or
- •received drugs that are UGT2B7 substrates (including Lorazepam, ibuprofen, valproic acid, naloxone and other morphine derivatives or propanolol)
研究者
相似试验
进行中（未招募）
不适用
Optimizing Pain Treatment in Pre-Term NeonatesEUCTR2011-001783-21-NLChildrens's Research Institute60
已完成
不适用
Morphine study.Preterm NeonatesMorphineCritically illPainNL-OMON24146Children's National Medical Center Washington30
已完成
2 期
Optimizing the Use of Morphine in Pre-Term NeonatesPremature NeonatesNCT00494429John van den Anker33
已完成
不适用
Therapeutic Touch for procedural pain in preterm neonates less than 28 weeks gestational ageISRCTN13204272SickKids Foundation (Canada)52
招募中
不适用
Pain Relief in Premature Newborns Through Maternal Intervention During VenipuncturePremature NewbornsNCT06200662University Hospital, Strasbourg, France48